Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Brain & Development|October 10, 2006
Motor and reflex testing in GM1-gangliosidosis model miceSatoshi Ichinomiya, Hiroshi Watanabe, Kimiko Maruyama, et al.
Gland Surgery|November 29, 2023
Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case reportSoji Toda, Yayoi Yamamoto, Yoichiro Ookubo, et al.
Gland Surgery|April 12, 2021
Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in lenvatinib treatment for anaplastic thyroid carcinomaHaruhiko Yamazaki, Hiroyuki Iwasaki, Nobuyasu Suganuma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2009
[Effectiveness of S-1 plus CPT-11 therapy for an elderly patient with recurrent colon cancer]Joji Samejima, Hiroyuki Iwasaki, Shinsuke Hatori, et al.
Medicine|March 12, 2019
Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancerHaruhiko Yamazaki, Hiroyuki Iwasaki, Hirotaka Takasaki, et al.
Anticancer Research|June 26, 2024
Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid CarcinomaSoji Toda, Nao Saito, Mei Kadoya, et al.
Oncology Letters|June 13, 2019
Treatment outcomes of differentiated thyroid cancer with distant metastasis improve by tyrosine kinase inhibitorsHiroyuki Iwasaki, Haruhiko Yamazaki, Hirotaka Takasaki, et al.
Nephrology (Carlton, Vic.)|February 26, 2025
A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck FractureToshiki Kano, Hiroaki Io, Yu Sasaki, et al.
Endocrine Journal|December 3, 2023
The frequency of mutations in advanced thyroid cancer in Japan: a single-center studySoji Toda, Hiroyuki Iwasaki, Yoichiro Okubo, et al.
JCO Precision Oncology|July 10, 2026
Real-World Genomic Characteristics and Prognostic Association in Advanced Papillary Thyroid CarcinomaSoji Toda, Yukihiko Hiroshima, Hiroyuki Iwasaki, et al.
Pageof 7